Intralesional Bevacizumab Injection on Primary Pterygium

A Randomized Controlled Trial of Intralesional Bevacizumab Injection on Primary Pterygium: Preliminary Results

The purpose of this study is to evaluate that intralesional injection of bevacizumab on primary pterygium can reduce the corneal pterygium area, inflammation, redness and other symptoms.

To evaluate the efficacy and safety of intralesional injection of bevacizumab on primary pterygium treatment

Inclusion Criteria:

• primary pterygium

Exclusion Criteria:

• previous ocular surgery